Clinical Trial Update: Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial updating on D-Cycloserine to enhance panic and smoking reduction treatment; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Addiction
• Panic Attack

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Texas at Austin | Conditions: Nicotine Addiction, Panic Attack | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-05-19